Free Trial

Direxion Daily S&P Biotech Bear 3x Shares (LABD) News Today

$6.60 -0.19 (-2.80%)
(As of 11/20/2024 ET)
Direxion Daily S&P Biotech Bear 3X ETF (LABD)
Direxion Daily S&P 500 Biotech Bull 3X Shares price
Want Diversified Upside in Biotechnology? Check out LABU (LABD)
Watch the Direxion Daily S&P 500 Biotech Bull 3X Shares (NYSEARCA: LABU) if you want a speculative play in the biotechnology industry with amplified volatility.
This Year's Most Shorted ETFs
5 Least-Hurt Biotech ETFs of the Last Week
LABU Direxion Daily S&P Biotech Bull 3x Shares ETF
The Sell Rating Of LABD Is Reaffirmed
LABD: A Bad Bad Drift
Biotech Bounces in August as M&A Activity Increases
Direxion Daily S&P Biotech Bear 3X ETF LABD
LABD Direxion Daily S&P Biotech Bear 3x Shares ETF
Biotech Belonged to the Bears in Second Half of 2021
Why Affirm Shares Are Falling
Worst Performing ETFs of 2020
Get Direxion Daily S&P Biotech Bear 3x Shares News Delivered to You Automatically

Sign up to receive the latest news and ratings for LABD and its competitors with MarketBeat's FREE daily newsletter.

War on Elon Escalates… (Ad)

A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

One company holds a near-total monopoly on it.

LABD Media Mentions By Week

LABD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

LABD
News Sentiment

0.00

0.56

Average

News Sentiment

LABD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

LABD Articles
This Week

0

0

LABD Articles
Average Week

Get Direxion Daily S&P Biotech Bear 3x Shares News Delivered to You Automatically

Sign up to receive the latest news and ratings for LABD and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSEARCA:LABD) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners